Odoamide is a novel cyclic depsipeptide with highly potent cytotoxic activity isolated from the Okinawan marine cyanobacterium Okeania sp. It contains a 26-membered macrocycle composed of a fatty acid moiety, a peptide segment and isoleucic acid. Four possible stereoisomers of the odoamide polyketide substructure were synthesised using a chiral pool approach. The first total synthesis of odoamide was also successfully achieved. The structure of synthetic odoamide was verified by comparing its NMR spectra with those of the natural product.
Introduction
Many peptide secondary metabolites derived from natural resources show attractive biological activities. 1 Because of their favourable drug-like properties including good membrane permeability and biostability, 2 a number of synthetic and medicinal chemistry studies of macrocyclic peptides and highly N-methylated peptides have been carried out. 3 Among them, aurilide-class cyclic depsipeptides exhibit highly potent antiproliferative activity against cancer cell lines (Fig. 1 ). The first 26-membered cyclic depsipeptide, aurilide (1a), was isolated from the sea hare Dolabella auricularia. 4 The related depsipeptides, aurilide B (1b) and C (1c), from Lyngbya majuscula also show potent cytotoxicity. 5 Kulokekahilide-2 (2) is a similar cytotoxic depsipeptide from a marine mollusk, Philinopsis speciosa, which has two conformers of the 26-membered macrocycle in dichloromethane. 6 Lagunamide A (3a) and B (3b) from Lyngbya majuscula exhibit antimalarial activity against Plasmodium falciparum at submicromolar concentrations. 7 Lagunamide C (3c) 8 and palau'amide (4) 9 exhibit cytotoxicity at nanomolar concentrations comparable to other aurilide-class depsipeptides, although these peptides have unique 27-membered and 24-membered macrocycles,
respectively. The configurations of the component amino acids of the depsipeptides were investigated by chiral HPLC, chiral GC-MS, and Marfey's analyses, 10 while the stereoselective synthesis and the NMR analysis facilitated the determination of the absolute stereochemistries of the fatty acid substructure. In some cases, the structure was verified or revised through synthetic studies of natural products and their stereoisomers.
11
Odoamide (5) is a novel cyclic depsipeptide from the Okinawan marine cyanobacterium Okeania sp. (Fig. 2A) , which shows highly potent cytotoxic activity against HeLa S 3 cell lines. 12 The overall structure of the 26-membered macrocycle is similar to those of aurilide-class depsipeptides, and comprises three substructures: a fatty acid moiety, a peptide segment (Ala-D-MePhe-Sar-Ile-MeAla) and isoleucic acid. At the initial stage of this study, the absolute configurations of the constituent amino acids and isoleucic acid in 5 were determined by chiral HPLC analysis and Marfey's analysis. The absolute configuration of the 5-hydroxy group of the polyketide part was determined by Mosher's method, 13 while the remaining configurations of the polyketide were ambiguous. In this study, we carried out a synthetic study of odoamide to verify its structure and complete stereochemistry. The synthetic strategy is illustrated in Scheme 1. During the cyclisation of the linear peptide, epimerisation and dimer formation are often problematic.
3e,f, 14 To avoid the less reactive process of N-methylated amide (CO-NMe) or ester bond formation compared with standard peptide bond (CO-NH) formation, we chose macrocyclisation of the Ala and D-alloisoleucic acid residues of the linear precursor 6 for odoamide (5) . 11d Peptide 6 could be prepared by coupling of alcohol 7, MeAla 8 and tetrapeptide 9, which could be obtained by standard solid-phase peptide synthesis. Alcohol 7 could be synthesised by coupling of D-allo-isoleucic acid ester 11 15 with carboxylic acid 10.
Results and discussion

Synthesis of the polyketide substructure of odoamide
The stereochemistries of the polyketide part were unknown when we started this study. Therefore, it was necessary to synthesise all the possible polyketide substructures of odoamide 5. The polyketide substructure in lagunamide A (3a), a closely related structural analogue of 5, has 5S,7R-dihydroxy and 6S,8S-dimethyl groups. Additionally, aurilide-class depsipeptides 1a-c, 2, and 3a,b possess the syn-1,3-diol moiety with a 5S-hydroxy configuration. On the basis of the structures of these related molecules, we expected that the plausible stereochemical configuration of the natural odoamide 5 was 5S,6S,7R,8S. Among these four stereocentres, the configuration at the C8-methyl group was ambiguous because attempts to determine it based on derivatisation and NMR analysis of odoamide (5) were unsuccessful. It was also desirable to confirm the stereochemistry of the C6-methyl group. Therefore, we designed four possible methyl esters 12a-d as polyketide substructure substrates (Fig. 2B) . Methyl esters 12a,b were synthesised from (S)-Roche ester 13 according to a similar process described in previous reports by us and others (see the ESI †).
11a,12 Preparation of (5S,6R,7R,8S)-ester 12c and (5S,6R,7R,8R)-ester 12d started from the commercially available (R)-Roche ester ent-13 in a similar manner (Scheme 2). (R)-Roche ester ent-13 was converted to alcohol ent-15 via benzyl protection 16 and LiAlH 4 -mediated reduction. After Swern oxidation, an n-Bu 2 BOTfmediated Evans aldol reaction 17 of the resulting aldehyde provided the syn-aldol products 16c and 17d. The requisite stereochemistries at the C8 chiral centre in 12c and 12d were generated at this step by using propionyl-and pentanoyl-oxazolidinones, respectively. TBS protection of the secondary alcohol in 16c and 17d followed by removal of the chiral auxiliary with LiBH 4 gave alcohols 20c 18 and 21d. Swern oxidation of 20c and the subsequent Wittig reaction of the resulting aldehyde with ethylidene-triphenylphosphorane provided olefin 22c as an E/Z isomeric mixture. Hydrogenation of 22c in the presence of Pd/C afforded the key alcohol 23c with a threo/ threo-configuration. Separately, tosylation of 21d followed by LiAlH 4 -mediated reduction afforded benzyl ether 24d, which was converted to the corresponding alcohol 23d (with a threo/ erythro-configuration) by hydrogenation. Swern oxidation of 23c followed by a Mukaiyama aldol reaction 19 with 1-methoxy-2-methyl-1-trimethylsiloxy-1,3-butadiene (25) 20 produced methyl ester 12c with a (5S)-hydroxy group (dr >99 : 1). 21 Ester 12d was obtained from 23d by using the identical protocol.
The stereochemistry of the 5-hydroxy group in alcohol 12a was confirmed by the NMR analysis of the corresponding acetonide (Scheme 3). TBS deprotection of 26a 22 and 12a provided 1,3-diols 27a and 28a, which were treated with 2,2-dimethoxypropane in the presence of PPTS to give acetonides 29a and 30a, respectively. It is known that 13 C NMR chemical shifts of the ketal methyl groups in syn-and anti-1,3-diol acetonides are different.
23 A syn-acetonide shows different chemical shifts for the two ketal methyl groups (e.g., 19.5 and 30.0 ppm for 30a) because of its predominant chair conformation. In contrast, an anti-acetonide shows close chemical shifts (e.g., 23.5 and 25.2 ppm for 29a), because the antiisomer exists in a twist-boat conformation to avoid the 1,3-diaxial interaction that would be present in the chair conformation. Accordingly, it was demonstrated that 1,3-diol 28a, the precursor of acetonide 30a has the desired 1,3-syn configuration. Of note, esters 12a-d were employed as the key substrates for the stereochemical assignment of the polyketide substructure in 5 in our previous research.
12
Manipulations of esters 12a-d including DIBAL-mediated reductive transformation provided the corresponding triol derivatives. The comparative NMR analysis between the natural product-derived triol and synthetic triols demonstrated that the polyketide substructure had the 5S,6S,7R,8S configuration (see the ESI †).
Synthesis of odoamide and its biological evaluation
After the determination of the stereochemistry of the polyketide part, 12 we attempted the total synthesis of odoamide 
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This journal is © The Royal Society of Chemistry 2016 using (5S,6S,7R,8S)-ester 12a. Synthesis of odoamide (5) began with methylthiomethyl (MTM) protection of the secondary hydroxy group in 12a to give thioacetal 31 (Scheme 4). 11a,24 Hydrolysis of 31 with LiOH followed by coupling with D-allo-isoleucic acid phenacyl ester (11) using 2-methyl-6-nitrobenzoic anhydride (MNBA) 25 and DMAP afforded ester 32. The TBS group in 32 was deprotected with HF·pyridine to produce the corresponding alcohol 7. In the coupling of Fmoc-MeAla-OH 8 with 7 using DCC and DMAP, significant epimerisation occurred. The coupling using Fmoc-MeAla-Cl 26 with 7 in the presence of DIPEA followed by Fmoc deprotection with Et 2 NH gave amine 33 in 54% yield (two steps) without epimerisation. Tetrapeptide 9 was conjugated with 33 using EDCI-HOAt to afford 34 as a 1.4 : 1 epimeric mixture at the α-position of Ile. 27 After removal of the phenacyl (with Zn and AcOH) and Fmoc groups (with Et 2 NH), the epimer mixture of the linear peptides was separated into the desired compound 6a (major, L-Ile) and undesired compound 6b (minor, D-allo-Ile) by HPLC purification. Cyclisation of 6a and 6b with HATU followed by deprotection of the MTM group with AgNO 3 and 2,6-lutidine gave the desired odoamide 5a and its diastereomer 5b. Both cyclisations of 6a and 6b proceeded smoothly within five hours without epimerisation. The configurations of L-Ile and D-allo-Ile in peptides 5a and 5b, respectively, were determined by Marfey's analysis and 1 H NMR analysis after acid hydrolysis. We analysed the 1 H NMR and 13 C NMR spectra of the natural and synthetic products ( Fig. 3 and 4) . The NMR spectra of the synthetic odoamide 5a were identical to those of the natural product 5, suggesting that the chemical structure of odoamide was the same as 5a. The cytotoxicity of synthetic odoamides 5a and 5b against A549 cells was also evaluated by the MTS assay. Peptide 5a showed highly potent cytotoxicity (IC 50 = 2.1 nM), corroborating our correct structural assignment of odoamide (5) . However, the epimer peptide 5b showed significantly less potent antiproliferative activity (IC 50 = 0.54 μM), suggesting that the L-Ile configuration is crucial for the cytotoxic activity of odoamide.
Conclusions
In this study, the total synthesis of odoamide was completed via the synthesis of four possible polyketide substructures 12a-d. The NMR spectra of the synthetic peptide 5a were identical to those of the natural odoamide 5. Accordingly, the full structural assignment and first total synthesis of odoamide were achieved. 
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Experimental section
Synthetic general method NMR spectra were recorded using a JEOL ECA-500 spectrometer. Chemical shifts are reported in δ ( ppm) relative to Me 4 Si (in CDCl 3 ) as an internal standard. 13 C NMR spectra were referenced to the residual solvent signal. Melting points were measured by a hot stage melting point apparatus (uncorrected). Exact mass (HRMS) spectra were recorded on a Shimadzu LC-ESI-IT-TOF-MS instrument. IR spectra were recorded on a JASCO FT/IR-4100 spectrometer. Optical rotations were measured with a JASCO P-1020 polarimeter. For flash chromatography, Wakogel C-300E (Wako) was employed.
For analytical HPLC, a Cosmosil 5C18-ARII column (4.6 × 250 mm, Nacalai Tesque, Inc.) was employed with a linear gradient of CH 3 CN (with 0.1% (v/v) TFA, except for the analysis of final products 5a,b using solvents without TFA) in H 2 O at a flow rate of 1 cm 3 min −1 , and eluting products were detected by UV at 220 nm. Preparative HPLC was performed using a Cosmosil 5C18-ARII preparative column (20 × 250 mm, Nacalai Tesque, Inc.) at a flow rate of 8 cm 3 min −1 . The purity of peptides 5a,b was determined by HPLC analysis (>95%). The synthetic procedures for esters 12a,b were described in our previous report.
12
Methyl (R)-3-benzyloxy-2-methylpropanoate (ent-14). To a stirred solution of ent-13 (9.9 g, 83.8 mmol) in CH 2 Cl 2 (210 cm 3 ) under argon were added benzyl 2,2,2-trichloroacetimidate (17.1 cm 3 , 92.2 mmol) in cyclohexane (420 cm 3 ) and triflic acid (3.0 cm 3 , 33.5 mmol) at 0°C. After 10 min, the reaction mixture was warmed to room temperature and stirred for 18 h. The precipitated trichloroacetamide was filtered off. The filtrate was washed with saturated aqueous NaHCO 3 and brine, and dried over MgSO 4 . The filtrate was concentrated under reduced pressure and the residue was purified by flash chromatography over silica gel with hexane-EtOAc (50 : 1 to 10 : 1) to give compound ent-14 (14.8 g, 85%) as a colorless oil. The spectral data were in good agreement with those previously reported.
28
(S)-3-Benzyloxy-2-methylpropan-1-ol (ent-15). To a stirred suspension of LiAlH 4 (4.0 g, 105.9 mmol) in THF (175 cm 3 )
under argon was added dropwise a solution of ent-14 (14.7 g, 70.6 mmol) in THF (175 cm 3 ) at 0°C. After stirring for 1 h, the reaction mixture was poured into a saturated aqueous solution of sodium potassium tartrate at 0°C and stirred overnight at room temperature. The whole mixture was extracted with Et 2 O and the extract was washed with brine, and dried over MgSO 4 . The filtrate was concentrated under reduced pressure and the residue was purified by flash chromatography over silica gel with hexane-EtOAc (9 : 1 to 3 : 1) to give compound ent-15 (10.3 g, 81%) as a colorless oil. The spectral data were in good agreement with those previously reported. 0.12 mmol) in THF (0.80 cm 3 ) and pyridine (0.20 cm 3 ) was added HF·pyridine (0.50 cm 3 ) at 0°C. The reaction mixture was warmed to room temperature and stirred overnight. The reaction mixture was poured into saturated aqueous NaHCO 3 at 0°C. The whole mixture was extracted with EtOAc, and the extract was washed with brine and 1 N HCl, and dried over MgSO 4 . The filtrate was concentrated under reduced pressure and the residue was purified by flash chromatography over silica gel with hexane-EtOAc 878.5254.
Growth inhibition assay
A549 cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Sigma) supplemented with 10% (v/v) fetal bovine serum at 37°C in a 5% CO 2 -incubator. Growth inhibition assays using A549 cells were performed in 96-well plates (BD Falcon). A549 cells were seeded at 500 cells per well in 0.050 cm 3 of culture media, respectively, and were cultured for 
